The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 2008

Filed:

Mar. 09, 2004
Applicants:

Isao Saito, Nagoya-city, Aichi-pref., 467-8530, JP;

Akimitsu Okamoto, Kyoto, JP;

Yoshio Saito, Kyoto, JP;

Yasuko Yoshida, Nagoya, JP;

Kousuke Niwa, Aichi, JP;

Inventors:

Isao Saito, Nagoya-city, Aichi-pref., 467-8530, JP;

Akimitsu Okamoto, Kyoto, JP;

Yoshio Saito, Kyoto, JP;

Yasuko Yoshida, Nagoya, JP;

Kousuke Niwa, Aichi, JP;

Assignees:

NGK Insulators, Ltd., Nagoya, JP;

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C07H 19/04 (2006.01); C12Q 1/68 (2006.01); G01N 33/53 (2006.01); C07H 21/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel nucleotide derivative, in case of existing as a member of a single-stranded sequence, undergoing a change in the fluorescent signal intendity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized, and which is a thymin/uracil derivative (1) emitting light most intensely when a confronting base in the partner strand with which the single-stranded nucleotide sequence is hybridized is adenine; a cytosine derivative (2) emitting light most intensely when the confronting base is guanine; an adenine derivative (3) emitting light most intensely when the confronting base is cytosine; a guanine derivative (4) emitting light most intensely when the confronting base is cytosine or thymine/uracil; and an adrnine derivative (5) emitting light most intensely when the confronting base is thymine/uracil/.


Find Patent Forward Citations

Loading…